These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 32205995

  • 1. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.
    Chen MY, Juengpanich S, Hu JH, Topatana W, Cao JS, Tong CH, Lin J, Cai XJ.
    World J Gastroenterol; 2020 Mar 14; 26(10):1042-1055. PubMed ID: 32205995
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ, Chen JZ, Li ZH, Bai T, Chen J, Zhu SL, Li LQ, Wu FX.
    World J Gastroenterol; 2017 Nov 07; 23(41):7415-7424. PubMed ID: 29151695
    [Abstract] [Full Text] [Related]

  • 3. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y, Lin K, Liu L, Qian Y, Yang Y, Yuan S, Zhu P, Huang J, Liu F, Gu F, Fu S, Jiang B, Liu H, Pan Z, Lau WY, Zhou W.
    Cancer Med; 2021 Mar 07; 10(6):2100-2111. PubMed ID: 33650288
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR, Tian MX, Tao CY, Tang Z, Zhou YF, Song SS, Jiang XF, Wang H, Zhou PY, Qu WF, Fang Y, Ding ZB, Zhou J, Fan J, Shi YH.
    BMC Cancer; 2020 Jul 10; 20(1):642. PubMed ID: 32650743
    [Abstract] [Full Text] [Related]

  • 5. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
    Gu J, Zhang X, Cui R, Zhang J, Wang Z, Jia Y, Miao R, Dong Y, Ma X, Fan H, Wang H, Ren L, Li Y, Niu W, Zhang J, Qu K, Liu C.
    Eur J Gastroenterol Hepatol; 2019 Jul 10; 31(7):836-844. PubMed ID: 30614882
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 7. Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study.
    Li M, Xin Y, Fu S, Liu Z, Li Y, Hu B, Chen S, Liang C, Lu L.
    Medicine (Baltimore); 2016 Jan 02; 95(2):e2458. PubMed ID: 26765441
    [Abstract] [Full Text] [Related]

  • 8. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization.
    Ke Q, Xiang F, Xiao C, Huang Q, Liu X, Zeng Y, Wang L, Liu J.
    BMC Cancer; 2021 Oct 18; 21(1):1117. PubMed ID: 34663242
    [Abstract] [Full Text] [Related]

  • 9. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb 18; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 10. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW, Chen YS, Lo GH, Hsu YC, Hsu CC, Wu TC, Yeh JH, Hsiao P, Hsieh PM, Lin HY, Shu CW, Hung CM.
    BMC Gastroenterol; 2020 Apr 10; 20(1):99. PubMed ID: 32272898
    [Abstract] [Full Text] [Related]

  • 11. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M.
    Eur Radiol; 2018 Aug 10; 28(8):3522-3531. PubMed ID: 29536241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
    Wang YY, Wang LJ, Xu D, Liu M, Wang HW, Wang K, Zhu X, Xing BC.
    HPB (Oxford); 2019 Apr 10; 21(4):425-433. PubMed ID: 30249510
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
    Zhang J, Peng H, Wang B, Luo L, Cheng Y, He G, Tang Y, Pan M.
    J Gastrointest Surg; 2021 Jul 10; 25(7):1770-1778. PubMed ID: 32748340
    [Abstract] [Full Text] [Related]

  • 16. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z, Chen S, Xiao H, Wang Y, Li J, Mei J, Chen Z, Zhou Q, Feng S, Chen M, Qian G, Peng S, Kuang M.
    Radiology; 2019 Jul 10; 292(1):237-247. PubMed ID: 31135299
    [Abstract] [Full Text] [Related]

  • 17. Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion.
    Sun JJ, Wang K, Zhang CZ, Guo WX, Shi J, Cong WM, Wu MC, Lau WY, Cheng SQ.
    Ann Surg Oncol; 2016 Apr 10; 23(4):1344-51. PubMed ID: 26714945
    [Abstract] [Full Text] [Related]

  • 18. Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis.
    Shen L, Chen S, Qiu Z, Qi H, Yuan H, Cao F, Xie L, Chen Q, Li W, Fan W.
    J Cancer Res Ther; 2020 Sep 10; 16(5):1063-1068. PubMed ID: 33004748
    [Abstract] [Full Text] [Related]

  • 19. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL, Xiao H, Xie ZL, Shen JX, Chen ZB, Wang YQ, Li B, Peng ZW, Kuang M, Lai JM, Peng S.
    Eur Radiol; 2020 Jun 10; 30(6):3473-3485. PubMed ID: 32048035
    [Abstract] [Full Text] [Related]

  • 20. Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.
    Hu H, Duan Z, Long X, Hertzanu Y, Shi H, Liu S, Yang Z.
    PLoS One; 2014 Jun 10; 9(5):e96620. PubMed ID: 24817002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.